SBC Medical Group Holdings Inc (SBC) Cash & Equivalents (2022 - 2026)

SBC Medical Group Holdings (SBC) has 4 years of Cash & Equivalents data on file, last reported at $163.8 million in Q4 2025.

• Quarterly Cash & Equivalents rose 30.97% year-over-year to $163.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $163.8 million (up 30.97% YoY) and the FY2025 annual result came in at $163.8 million, up 30.97% from the prior year.
• Cash & Equivalents improved to $163.8 million in Q4 2025, from $127.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $163.8 million in Q4 2025 to a low of $217348.0 in Q1 2023.
• A 4-year average of $78.7 million and a median of $114.0 million in 2023 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 52722.33% in 2025, down 7.25% in 2025.
• Tracing SBC's Cash & Equivalents over 4 years: stood at $485564.0 in 2022, then surged by 21117.17% to $103.0 million in 2023, then advanced by 21.38% to $125.0 million in 2024, then jumped by 30.97% to $163.8 million in 2025.
• The last three Cash & Equivalents figures came in at $163.8 million (Q4 2025), $127.4 million (Q3 2025), and $152.7 million (Q2 2025), per Business Quant data.